126 related articles for article (PubMed ID: 37358357)
1. Microglial cytokines poison neuronal autophagy via CCR5, a druggable target.
Festa BP; Siddiqi FH; Jimenez-Sanchez M; Rubinsztein DC
Autophagy; 2024 Apr; 20(4):949-951. PubMed ID: 37358357
[TBL] [Abstract][Full Text] [Related]
2. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration.
Festa BP; Siddiqi FH; Jimenez-Sanchez M; Won H; Rob M; Djajadikerta A; Stamatakou E; Rubinsztein DC
Neuron; 2023 Jul; 111(13):2021-2037.e12. PubMed ID: 37105172
[TBL] [Abstract][Full Text] [Related]
3. G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity.
Gamo K; Kiryu-Seo S; Konishi H; Aoki S; Matsushima K; Wada K; Kiyama H
J Neurosci; 2008 Nov; 28(46):11980-8. PubMed ID: 19005063
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
Louboutin JP; Strayer DS
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.
Xia MQ; Qin SX; Wu LJ; Mackay CR; Hyman BT
Am J Pathol; 1998 Jul; 153(1):31-7. PubMed ID: 9665462
[TBL] [Abstract][Full Text] [Related]
7. AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance.
Benito-Cuesta I; Ordóñez-Gutiérrez L; Wandosell F
Autophagy; 2021 Mar; 17(3):656-671. PubMed ID: 32075509
[TBL] [Abstract][Full Text] [Related]
8. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.
Liu W; Liu D; Zheng J; Shi P; Chou PH; Oh C; Chen D; An HS; Chee A
Spine J; 2017 May; 17(5):720-726. PubMed ID: 28108404
[TBL] [Abstract][Full Text] [Related]
9. CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism.
Shideman CR; Hu S; Peterson PK; Thayer SA
J Neurosci Res; 2006 Jun; 83(8):1471-84. PubMed ID: 16547971
[TBL] [Abstract][Full Text] [Related]
10. C-C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation.
Park JH; Lee DH; Park MS; Jung YS; Hong JT
J Gastroenterol Hepatol; 2017 Jun; 32(6):1258-1264. PubMed ID: 27859576
[TBL] [Abstract][Full Text] [Related]
11. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain.
Sun S; Chen D; Lin F; Chen M; Yu H; Hou L; Li C
Mol Immunol; 2016 Sep; 77():184-92. PubMed ID: 27522478
[TBL] [Abstract][Full Text] [Related]
14. Dual regulation of microglia and neurons by Astragaloside IV-mediated mTORC1 suppression promotes functional recovery after acute spinal cord injury.
Lin J; Pan X; Huang C; Gu M; Chen X; Zheng X; Shao Z; Hu S; Wang B; Lin H; Wu Y; Tian N; Wu Y; Gao W; Zhou Y; Zhang X; Wang X
J Cell Mol Med; 2020 Jan; 24(1):671-685. PubMed ID: 31675186
[TBL] [Abstract][Full Text] [Related]
15. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
16. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
17. Rubratoxin-B-induced secretion of chemokine ligands of cysteine-cysteine motif chemokine receptor 5 (CCR5) and its dependence on heat shock protein 90 in HL60 cells.
Nagashima H
Environ Toxicol Pharmacol; 2015 Nov; 40(3):997-1000. PubMed ID: 26595743
[TBL] [Abstract][Full Text] [Related]
18. The role of autophagy in pro-inflammatory responses of microglia activation via mitochondrial reactive oxygen species in vitro.
Ye J; Jiang Z; Chen X; Liu M; Li J; Liu N
J Neurochem; 2017 Jul; 142(2):215-230. PubMed ID: 28407242
[TBL] [Abstract][Full Text] [Related]
19. The intricate role of CCL5/CCR5 axis in Alzheimer disease.
Ma W; Liu A; Wu X; Gao L; Chen J; Wu H; Liu M; Fan Y; Peng L; Yang J; Kong J; Li B; Ji Z; Dong Y; Luo S; Song J; Bao F
J Neuropathol Exp Neurol; 2023 Oct; 82(11):894-900. PubMed ID: 37769321
[TBL] [Abstract][Full Text] [Related]
20. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
Gonek M; McLane VD; Stevens DL; Lippold K; Akbarali HI; Knapp PE; Dewey WL; Hauser KF; Paris JJ
Brain Behav Immun; 2018 Mar; 69():124-138. PubMed ID: 29146238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
